Compare Cassava Sciences Inc (FLNA) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs United States Oil ETF — how do they compare? Cassava Sciences Inc trades at $0.82 (market cap $39.40M), while United States Oil ETF trades at $148.2 (market cap $1.90B). The key difference: United States Oil ETF is far larger — about 48.2× Cassava Sciences Inc's market cap, and United States Oil ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and United States Oil ETF for 21 Days on average.
| FLNA | USO | |
|---|---|---|
Market Cap | $39.40M | $1.90B |
Volume | 759,018 | 5,932,922 |
Sector | Health | — |
52-Week High | $4.64 | $161.86 |
52-Week Low | $0.68 | $66.17 |
Typical Hold Time | 37 Days | 21 Days |
Enterprise Value | -$43.28M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.8136, down 0.26% today, with a bearish technical signal from moving averages but neutral oscillators. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though it has beaten EPS estimates in recent quarters. Recent positive news includes FDA lifting a clinical hold on its epilepsy drug, enabling Phase 2a studies.
The outlook remains high-risk due to persistent negative cash flows and lack of revenue, but analyst consensus is bullish with 67% buy ratings. Key risks include clinical trial execution and funding needs, while the FDA decision provides a potential catalyst for long-term investors focused on biotech turnaround stories.
USO is trading at $147.58, up 2.55% with a bullish technical signal supported by moving averages. Recent news highlights Middle East tensions affecting oil supply, with OPEC+ maintaining output targets and G-7 planning strategic oil releases. The stock shows strength above key support levels amid volatile energy market conditions.
The outlook remains cautiously optimistic given geopolitical risks and supply constraints. Investment opportunities include potential price appreciation from supply disruptions, while risks involve oil price volatility and regulatory pressures from climate litigation. Institutional sentiment appears mixed with neutral oscillators suggesting near-term consolidation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
